NCC-MFS3-C1

$600$1,500

Description

Cell line name NCC-MFS3-C1
Accession CVCL_B3RM
Resource Identification Initiative To cite this cell line use: NCC-MFS3-C1 (RRID:CVCL_B3RM)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: ~36 hours (PubMed=33990915).
Omics: SNP array analysis.
Derived from site: In situ; Thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
Sequence variations
Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Unspecified (PubMed=33990915).
Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Unspecified (PubMed=33990915).
Disease Myxofibrosarcoma (NCIt: C6496)
Myxofibrosarcoma (ORDO: Orphanet_79105)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 74Y
Category Cancer cell line
STR profile

Source(s): PubMed=33990915

Markers:

Amelogenin X
CSF1PO 10
D5S818 11
D7S820 10,11
D13S317 10
D16S539 12,13
D21S11 30
TH01 7,9
TPOX 8
vWA 17

Publications
PubMed=33990915; DOI=10.1007/s13577-021-00548-6
Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Sei A., Takeshita F., Sugaya J., Iwata S., Yoshida A., Ohtori S., Kawai A., Kondo T.
Establishment and characterization of NCC-MFS3-C1: a novel patient-derived cell line of myxofibrosarcoma.
Hum. Cell 34:1266-1273(2021)

Cross-references
Encyclopedic resources Wikidata; Q110433085

Additional information

ユーザー種別

Academia/non-profit organization, For-profit organization

Reviews

There are no reviews yet.

Be the first to review “NCC-MFS3-C1”

Your email address will not be published. Required fields are marked *

CAPTCHA